1.Cutaneous Adverse Drug Reactions in a General Hospital in Singapore: A One-Year Retrospective Analysis
Rachael YL Teo ; Yong Kwang Tay ; Kwong Ming Fock
Malaysian Journal of Dermatology 2007;19(-):79-82
Background Rashes are the most common adverse reaction to drugs. Our aim is to describe (i) the prevalence of cutaneous adverse drug reactions in hospitalised patients over a 1-year period in our hospital;
(ii) the variety of cutaneous drug reactions; (iii) the characteristics of patients with cutaneous drug reactions and (iv)the drugs implicated.
Methods A retrospective analysis of all adverse drug reactions from the pharmacists’ database from January to December 2003 was conducted. Patients’ records were reviewed to extract demographic data, drug implicated, route of administration, drug allergy history, type
of cutaneous reaction, severity and presence of underlying chronic disease.
Results Sixty-five patients met our inclusion criteria, giving an estimated prevalence of 1.8/1000 among hospitalised patients. The cases were mostly from the general medicine department (64.6%), with
a slight male predominance (males, 53.8%; females 46.2%). Cutaneous adverse drug reactions were more common in the Malay population (32.3%). The mean age was 41.6 years (range, 13 to 85 years). The main drugs implicated were antibiotics (49.2%), mainly penicillins and
cephalosporins, and non-steroidal anti-inflammatory agents (16.9%). Urticarial (46.1%) and generalised maculopapular eruptions (40.0%) were the most common patterns encountered. Others included Stevens-Johnson syndrome/toxic epidermal necrolysis (7.7%), drug
reaction with eosinophilia and systemic symptoms (1.5%) and
erythroderma (1.5%). 29.2% of cases were considered to be severe. There were no deaths. 44.6% had an associated chronic disease and 24.6% had a previous documented drug allergy.
Conclusion Antibiotics and NSAIDs were the major drugs involved. The commonest cutaneous manifestations were urticarial and maculopapular eruptions. A high proportion of reactions were considered severe and almost one-quarter had a previous drug allergy.
2.Screening Colonoscopy for Average Risk Individuals in Singapore.
Tiing Leong ANG ; Kwong Ming FOCK
Intestinal Research 2012;10(3):219-228
In Singapore colorectal cancer (CRC) is the most common cancer for males, second most common cancer for females and most common cancer overall. A national CRC screening program for average risks individuals was started in July 2011, with the primary test modality being the faecal immunochemical test. Individuals may choose to undergo screening colonoscopy directly. Colonoscopy has two roles in CRC screening. It is performed either as a primary screening test or used to evaluate abnormal results from another screening test. Colonoscopy is a safe and effective procedure but potential risks exist. Local complications such as perforation and bleeding, cardiopulmonary events and even mortality may occur. Additionally there could be failed cecal intubation and missed lesions. It is imperative that prior to colonoscopy, there is a proper discussion of risks, benefits and alternatives. To provide quality assurance for colonoscopy in the CRC screening program, a set of quality indicators and criteria for endoscopists and endoscopy centres was established. The endoscopists must be qualified specialists with a lifetime experience of at least 500 colonoscopies and 50 polypectomies, and need to meet annual monitoring parameters that include at least 50 colonoscopies, >95% cecal intubation rate, >95% recovery rate of excised polyps, and withdrawal time of at least 6 minutes. In addition, complication rates must be within acceptable limits such as perforation rate of less than 0.1% and postpolypectomy bleeding rate less than 1%.
Colonic Neoplasms
;
Colonoscopy
;
Colorectal Neoplasms
;
Endoscopy
;
Female
;
Hemorrhage
;
Humans
;
Intubation
;
Male
;
Mass Screening
;
Polyps
;
Quality Indicators, Health Care
;
Singapore
;
Specialization
4.Healthcare in Singapore: the present and future.
Choon How HOW ; Kwong Ming FOCK
Singapore medical journal 2014;55(3):126-127
5.Current status of functional gastrointestinal evaluation in clinical practice.
Daphne ANG ; Kwong Ming FOCK ; Ngai Moh LAW ; Tiing Leong ANG
Singapore medical journal 2015;56(2):69-quiz 80
Neurogastroenterology and motility disorders of the gastrointestinal (GI) tract encompass a broad spectrum of diseases involving the GI tract and central nervous system. They have varied pathophysiology, clinical presentation and management, and make up a substantial proportion of outpatient clinic visits. Typically, patients experience persistent symptoms referable to the GI tract despite normal endoscopic and radiologic findings. An appropriate evaluation is thus important in the patient's care. Advances in technology and understanding of the disease pathophysiology have provided better insight into the physiological basis of disease and a more rational approach to patient management. While technological advances serve to explain patients' persistent symptoms, they should be balanced against the costs of diagnostic tests. This review highlights the GI investigative modalities employed to evaluate patients with persistent GI symptoms in the absence of a structural lesion, with particular emphasis on investigative modalities available locally and the clinical impact of such tools.
Electrophysiology
;
Endoscopy
;
Esophagus
;
physiopathology
;
Gastric Emptying
;
Gastroenterology
;
instrumentation
;
methods
;
Gastrointestinal Diseases
;
diagnosis
;
Gastrointestinal Tract
;
physiopathology
;
Humans
;
Hydrogen-Ion Concentration
;
Intestine, Small
;
physiopathology
;
Magnetic Resonance Imaging
6.EUS-FNA of the left adrenal gland is safe and useful.
Tiing Leong ANG ; Tju Siang CHUA ; Kwong Ming FOCK ; Augustine K H TEE ; Eng Kiong TEO ; Kent MANCER
Annals of the Academy of Medicine, Singapore 2007;36(11):954-957
INTRODUCTIONThere are limited data on the use of endosonography-guided fine-needle aspiration (EUS-FNA) to determine the nature of left adrenal lesions. We described our experience in performing EUS-FNA of left adrenal lesions.
CLINICAL PICTUREDuring a 20-week period, data on consecutive patients who underwent EUS with or without EUS-FNA were prospectively captured. Patients with a left adrenal mass and who underwent EUS-FNA formed our study population.
TREATMENTEUS-FNA.
OUTCOMEA total of 119 consecutive patients underwent diagnostic EUS +/- FNA, during which the left adrenal gland was routinely examined. Twelve of these patients underwent EUS as part of lung cancer staging and among these 12 lung cancer patients, 2 had left adrenal masses detected by computed tomography (CT). EUS detected left adrenal nodules in 2 other patients which were not visualised by CT. The overall prevalence of a left adrenal mass was 3.4%; in the subgroup with confirmed lung cancer, the prevalence was 33.3%. All 4 patients were male, with a mean age of 76.3 years (range, 67 to 87). The mean size of the left adrenal lesion was 30.4 mm (range, 9 to 84.8). EUS-FNA of the left adrenal lesions was performed under Doppler guidance. The mean number of needle passes was 2 (range, 1 to 4). A cellular aspirate was obtained in all patients. No procedural complications occurred. Metastatic non-small cell lung cancer was diagnosed in 2 patients, including a lesion missed on CT. For the other 2 cases, EUS-FNA revealed benign adrenal cells.
CONCLUSIONSEUS-FNA appears safe and useful for the evaluation of left adrenal masses.
Adrenal Gland Neoplasms ; diagnostic imaging ; pathology ; Aged ; Aged, 80 and over ; Biopsy, Fine-Needle ; adverse effects ; methods ; Endosonography ; adverse effects ; Humans ; Prospective Studies ; Singapore
7.Direct endoscopic necrosectomy: a minimally invasive endoscopic technique for the treatment of infected walled-off pancreatic necrosis and infected pseudocysts with solid debris.
Tiing Leong ANG ; Andrew Boon Eu KWEK ; Siong San TAN ; Salleh IBRAHIM ; Kwong Ming FOCK ; Eng Kiong TEO
Singapore medical journal 2013;54(4):206-211
INTRODUCTIONEndoscopic transenteric stenting is the standard treatment for pseudocysts, but it may be inadequate for treating infected collections with solid debris. Surgical necrosectomy results in significant morbidity. Direct endoscopic necrosectomy (DEN), a minimally invasive treatment, may be a viable option. This study examined the efficacy and safety of DEN for the treatment of infected walled-off pancreatic necrosis and infected pseudocysts with solid debris.
METHODSThis study was a retrospective analysis of data collected from a prospective database of patients who underwent DEN in the presence of infected walled-off pancreatic necrosis or infected pseudocysts with solid debris from April 2007 to October 2011. DEN was performed as a staged procedure. Endoscopic ultrasonography-guided transgastric stenting was performed during the first session for initial drainage and to establish endoscopic access to the infected collection. In the second session, the drainage tract was dilated endoscopically to allow transgastric passage of an endoscope for endoscopic necrosectomy. Outcome data included technical success, clinical success and complication rates.
RESULTSEight patients with infected walled-off pancreatic necrosis or infected pseudocysts with solid debris (mean size 12.5 cm; range 7.8-17.2 cm) underwent DEN. Underlying aetiologies included severe acute pancreatitis (n = 6) and post-pancreatic surgery (n = 2). DEN was technically successful in all patients. Clinical resolution was achieved in seven patients. One patient with recurrent collection opted for surgery instead of repeat endotherapy. No procedural complications were encountered.
CONCLUSIONDEN is a safe and effective minimally invasive treatment for infected walled-off pancreatic necrosis and infected pseudocysts.
Adult ; Aged ; Cysts ; diagnosis ; diagnostic imaging ; Endoscopy ; methods ; Female ; Humans ; Male ; Middle Aged ; Minimally Invasive Surgical Procedures ; methods ; Necrosis ; Pancreas ; pathology ; Pancreatic Diseases ; diagnosis ; diagnostic imaging ; surgery ; Pancreatitis, Acute Necrotizing ; diagnostic imaging ; surgery ; therapy ; Singapore ; Stents ; Treatment Outcome ; Ultrasonography
8.Clinical epidemiology of gastric cancer.
Tiing Leong ANG ; Kwong Ming FOCK
Singapore medical journal 2014;55(12):621-628
Gastric cancer is the second leading cause of cancer-related mortality and the fourth most common cancer globally. There are, however, distinct differences in incidence rates in different geographic regions. While the incidence rate of gastric cancer has been falling, that of gastric cardia cancers is reportedly on the rise in some regions. Helicobacter pylori (H. pylori) infection is a major risk factor of non-cardia gastric cancer, and data has emerged concerning the role of H. pylori eradication for primary prevention of gastric cancer. Dietary, lifestyle and metabolic factors have also been implicated. Although addressing these other factors may contribute to health, the actual impact in terms of cancer prevention is unclear. Once irreversible histological changes have occurred, endoscopic surveillance would be necessary. A molecular classification system offers hope for molecularly tailored, personalised therapies for gastric cancer, which may improve the prognosis for patients.
Female
;
Global Health
;
Helicobacter Infections
;
complications
;
prevention & control
;
Helicobacter pylori
;
Humans
;
Incidence
;
Male
;
Obesity
;
complications
;
Risk Factors
;
Stomach Neoplasms
;
epidemiology
;
genetics
;
microbiology
;
prevention & control
9.The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
Yu Jun WONG ; Prem Harichander THURAIRAJAH ; Rahul KUMAR ; Kwong Ming FOCK ; Ngai Moh LAW ; Sin-Yoong CHONG ; Fria Gloriba MANEJERO ; Tiing-Leong ANG ; Eng Kiong TEO ; Jessica TAN
Clinical and Molecular Hepatology 2021;27(3):474-485
Background/Aims:
Despite the disproportionally high prevalence rates of hepatitis C virus (HCV) amongst the incarcerated population, eradication remains challenging due to logistic and financial barriers. Although treatment prioritization based on disease severity is commonly practiced, the efficacy of such approach remained uncertain. We aimed to compare the impact of unrestricted access to direct-acting antiviral (DAA) among incarcerated HCV-infected patients in Singapore.
Methods:
In this retrospective study, we reviewed all incarcerated HCV-infected patients treated in our hospital during the restricted DAA era (2013–2018) and unrestricted DAA access era (2019). Study outcomes included the rate of sustained virological response (SVR), treatment completion and treatment default. Subgroup analysis was performed based on the presence of liver cirrhosis, HCV genotype and HCV treatment types.
Results:
A total of 1,001 HCV patients was followed-up for 1,489 person-year. They were predominantly male (93%) with genotype-3 HCV infection (71%), and 38% were cirrhotic. The overall SVR during the restricted DAA access era and unrestricted DAA access era were 92.1% and 99.1%, respectively. Unrestricted access to DAA exponentially improved the treatment access among HCV-infected patients by 460%, resulting in a higher SVR rate (99% vs. 92%, P=0.003), higher treatment completion rate (99% vs. 93%, P<0.001) and lower treatment default rate (1% vs. 9%, P<0.001).
Conclusion
In this large cohort of incarcerated HCV-infected patients, we demonstrated that unrestricted access to DAA is an impactful strategy to allow rapid treatment up-scale in HCV micro-elimination.
10.The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
Yu Jun WONG ; Prem Harichander THURAIRAJAH ; Rahul KUMAR ; Kwong Ming FOCK ; Ngai Moh LAW ; Sin-Yoong CHONG ; Fria Gloriba MANEJERO ; Tiing-Leong ANG ; Eng Kiong TEO ; Jessica TAN
Clinical and Molecular Hepatology 2021;27(3):474-485
Background/Aims:
Despite the disproportionally high prevalence rates of hepatitis C virus (HCV) amongst the incarcerated population, eradication remains challenging due to logistic and financial barriers. Although treatment prioritization based on disease severity is commonly practiced, the efficacy of such approach remained uncertain. We aimed to compare the impact of unrestricted access to direct-acting antiviral (DAA) among incarcerated HCV-infected patients in Singapore.
Methods:
In this retrospective study, we reviewed all incarcerated HCV-infected patients treated in our hospital during the restricted DAA era (2013–2018) and unrestricted DAA access era (2019). Study outcomes included the rate of sustained virological response (SVR), treatment completion and treatment default. Subgroup analysis was performed based on the presence of liver cirrhosis, HCV genotype and HCV treatment types.
Results:
A total of 1,001 HCV patients was followed-up for 1,489 person-year. They were predominantly male (93%) with genotype-3 HCV infection (71%), and 38% were cirrhotic. The overall SVR during the restricted DAA access era and unrestricted DAA access era were 92.1% and 99.1%, respectively. Unrestricted access to DAA exponentially improved the treatment access among HCV-infected patients by 460%, resulting in a higher SVR rate (99% vs. 92%, P=0.003), higher treatment completion rate (99% vs. 93%, P<0.001) and lower treatment default rate (1% vs. 9%, P<0.001).
Conclusion
In this large cohort of incarcerated HCV-infected patients, we demonstrated that unrestricted access to DAA is an impactful strategy to allow rapid treatment up-scale in HCV micro-elimination.